AM2 plays an essential role in the nexus of obesity and thyroid cancer, and the level of AM2 could be used as a biomarker for predicting thyroid tumor progression [280]. This evidence concerns the gene ADM2 and obesity due to melanocortin 4 receptor deficiency.